Cargando…
mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline
Lymphangioleiomyomatosis (LAM) is a rare fatal cystic lung disease due to bi-allelic inactivating mutations in tuberous sclerosis complex (TSC1/TSC2) genes coding for suppressors of the mechanistic target of rapamycin complex 1 (mTORC1). The origin of LAM cells is still unknown. Here, we profile a L...
Autores principales: | Obraztsova, Kseniya, Basil, Maria C., Rue, Ryan, Sivakumar, Aravind, Lin, Susan M., Mukhitov, Alexander R., Gritsiuta, Andrei I., Evans, Jilly F., Kopp, Meghan, Katzen, Jeremy, Robichaud, Annette, Atochina-Vasserman, Elena N., Li, Shanru, Carl, Justine, Babu, Apoorva, Morley, Michael P., Cantu, Edward, Beers, Michael F., Frank, David B., Morrisey, Edward E., Krymskaya, Vera P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648630/ https://www.ncbi.nlm.nih.gov/pubmed/33159078 http://dx.doi.org/10.1038/s41467-020-18979-4 |
Ejemplares similares
-
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
por: Evans, Jilly Frances, et al.
Publicado: (2021) -
Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor
por: Evans, Jilly F., et al.
Publicado: (2019) -
Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018) -
Syndecan-2: Old Player in a New Field
por: Obraztsova, Kseniya, et al.
Publicado: (2019) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)